UK authorizes Merck/Ridgeback Biotherapeutics' antiviral molnupiravir to treat mild-to-moderate Covid-19 - CNN

Generating your feed, please be patient ...

UK authorizes Merck/Ridgeback Biotherapeutics' antiviral molnupiravir to treat mild-to-moderate Covid-19 - CNN | Zootzle